Patents by Inventor Michael Clinton KOETTING

Michael Clinton KOETTING has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hydroxypyridoxazepines as NRF2 activators
    Patent number: 11945826
    Abstract: The present invention relates hydroxypyridoxazepine compounds, methods of making them, pharmaceutical compositions containing them and their use as Nrf2 activators. In particular, the invention relates to compounds of Formula (I), and pharmaceutically acceptable salts thereof, or a tautomer thereof, or a hydrate thereof.
    Type: Grant
    Filed: February 11, 2020
    Date of Patent: April 2, 2024
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Mark Elban, Michal Pawel Glogowski, Michael Clinton Koetting, Brian Griffin Lawhorn, Jay M. Matthews, Jaclyn Renee Patterson
  • HYDROXYPYRIDOXAZEPINES AS NRF2 ACTIVATORS
    Publication number: 20220204526
    Abstract: The present invention relates hydroxypyridoxazepine compounds, methods of making them, pharmaceutical compositions containing them and their use as Nrf2 activators. In particular, the invention relates to compounds of Formula (I), and pharmaceutically acceptable salts thereof, or a tautomer thereof, or a hydrate thereof.
    Type: Application
    Filed: February 11, 2020
    Publication date: June 30, 2022
    Inventors: Mark ELBAN, Michal Pawel GLOGOWSKI, Michael Clinton KOETTING, Brian Griffin LAWHORN, Jay M. MATTHEWS, Jaclyn Renee PATTERSON